One of the key pillars of the Egyptian economic reform adopted in 2016 was to raise the export rate. Since the pharmaceutical sector is one of Egypt's most established industries, the Egyptian government worked on a national plan to support the exports of medicines. Despite the impact of pharmaceutical exports on economic growth, there was limited research on this topic in Egypt. This study aims to provide a better knowledge of the problems of exporting medications in Egypt by investigating barriers and Covid-19 influence on pharmaceutical export. In-depth semi-structured interviews with representatives from pharmaceutical exporting companies have been conducted. The study’s main findings are divided into four groups; problems connected to the export country, such as procedural restrictions in the regulatory bodies; restrictions related to importing countries, such as information barriers and drug smuggling; issues related to the company, such as the qualification of the manufacturing site and the staff; problems with intellectual property rights. The data also demonstrated that the Egyptian government exerted significant efforts to support export. Finally, some recommendations for the government and companies are suggested to overcome these barriers and enhance pharmaceutical exports.


School of Global Affairs and Public Policy


Public Policy & Administration Department

Degree Name

MA in Public Policy

Graduation Date

Fall 1-31-2023

Submission Date


First Advisor

Dr. Ghada Barsoum

Committee Member 1

Dr. Rana Hendy

Committee Member 2

Dr. Islam Anan


87 p.

Document Type

Master's Thesis

Institutional Review Board (IRB) Approval

Approval has been obtained for this item

Available for download on Friday, September 13, 2024